Aug. 23 -- ChemChina has won U.S. approval for its $43B takeover of Syngenta. That was seen as the biggest regulatory hurdle in the pursuit of this Swiss agrichemical and seed company. Bloomberg's Jonathan Browning reports on "Trending Business."
GET REGULAR UPDATES

MUST WATCH VIDEOS

IPO Adda | Indegene Management On IPO Plans | NDTV Profit

IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit

NDTV Profit

IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit

NDTV Profit

TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit

NDTV Profit

Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit

NDTV Profit

Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships

NDTV Profit

View All